An instrumental variable approach finds no associated harm or benefit with early dialysis initiation in the United States

Kidney International

Volumn 86, Issue 4, 2014, Pages 798-809

  Scialla, Julia J ^a   Liu, Jiannong ^b   Crews, Deidra C ^c,d   Guo, Haifeng ^b   Bandeen Roche, Karen ^e   Ephraim, Patti L ^d,e   Tangri, Navdeep ^f   Sozio, Stephen M ^c,d   Shafi, Tariq ^c,d   Miskulin, Dana C ^g   Michels, Wieneke M ^c,d,h,o   Jaar, Bernard G ^c,d,e,i   Wu, Albert W ^c,e   Powe, Neil R ^j   Boulware, Ebony L ^c,d,e,k   Cook, Courtney ^l   Coresh, Josef ^l   Kim, Jeonyong ^l   Liu, Yang ^l   Luly, Jason ^l   McDermott, Aidan ^l   Scheel, Paul ^l   Zhou, Jing ^l   Collins, Allan ^c   Foley, Robert ^c   Gilbertson, David ^c   Heubner, Brooke ^c   Herzog, Charles ^c   St Peter, Wendy ^c   Nally, Joseph ^j   Arrigain, Susana ^j   Jolly, Stacey ^j   Konig, Vicky ^j   Liu, Xiaobo ^j   Navaneethan, Sankar ^j   Schold, Jesse ^j   Zager, Phil ^m   Meyer, Klemens ⁿ   more..

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF MANITOBA   (Canada)

^g TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h ACADEMIC MEDICAL CENTER   (Netherlands)

ⁱ NEPHROLOGY CENTER OF MARYLAND   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l JOHNS HOPKINS UNIVERSITY   (United States)

^m LERNER RESEARCH INSTITUTE   (United States)

ⁿ UNIVERSITY OF NEW MEXICO   (United States)

^o TUFTS UNIVERSITY   (United States)

more..

Author keywords

dialysis; end stage renal disease; epidemiology and outcomes; glomerular filtration rate

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DEMOGRAPHY; EARLY INTERVENTION; END STAGE RENAL DISEASE; FEMALE; GEOGRAPHIC DISTRIBUTION; GLOMERULUS FILTRATION RATE; HEALTH CARE FACILITY; HEMODIALYSIS; HUMAN; MALE; MORTALITY; NEPHROLOGIST; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME; TREND STUDY; UNITED STATES; ADOLESCENT; ADVERSE EFFECTS; EPIDEMIOLOGY; FACTUAL DATABASE; MIDDLE AGED; PATHOPHYSIOLOGY; REGISTER; RENAL INSUFFICIENCY, CHRONIC; RESIDENTIAL CARE; STATISTICS; STATISTICS AND NUMERICAL DATA; TIME; TRENDS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CATCHMENT AREA (HEALTH); DATABASES, FACTUAL; EARLY MEDICAL INTERVENTION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; REGISTRIES; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; STATISTICS AS TOPIC; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84910647571     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.110     Document Type: Article

References (43)

1. Ledebo I, Ml Kessler, van Biesen W et al. Initiation of dialysis-opinions from an international survey: report on the Dialysis Opinion Symposium at the ERA-EDTA Congress, 18 September 2000, Nice. Nephrol Dial Transplant 2001; 16: 1132-1138.
2. Obrador GT, Pereira BJ. Initiation of dialysis: current trends and the case for timely initiation. Perit Dial Int 2000; 20: S142-S149.
3. Pollock CA, Cooper BA, Harris DC. When should we commence dialysis? The story of a lingering problem and today's scene after the IDEAL study. Nephrol Dial Transplant 2012; 27: 2162-2166.
4. Korevaar JC, Jansen MAM, Dekker FW et al. When to initiate dialysis: effect of proposed US guidelines on survival. Lancet 2001; 358: 1046-1050.
5. Rosansky SJ. The sad truth about early initiation of dialysis in elderly patients. JAMA 2012; 307: 1919-1920.
6. National Kidney Foundation. NKF-KDOQI Clinical Practice Guidelines. Am J Kidney Dis 1997; 30: S67-S136.
7. National Kidney Foundation. KDOQI Clinical practice guidelines and clinical practice recommendations for 2006 updates: hemodialysis adequacy, peritoneal dialysis adequacy and vascular access. Am J Kidney Dis 2006; 48: S1-S322.
8. O'Hare A, Choi A, Boscardin W et al. Trends in timing of initiation of chronic dialysis in the United States. Arch Intern Med 2011; 171: 1663-1669.
9. Cooper BA, Branley P, Bulfone L et al. A randomized, controlled trial of early vs. late initiation of dialysis. N Engl J Med 2010; 363: 609-619.
10. United States Renal Data System. USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD, USA, 2011.
11. Susantitaphong P, Altamimi S, Ashkar M et al. GFR at initiation of dialysis and mortality in CKD: a meta-analysis. Am J Kidney Dis 2012; 59: 829-840.
12. Traynor JP, Simpson K, Geddes CC et al. Early initiation of dialysis fails to prolong survival in patients with end-stage renal failure. J Am Soc Nephrol 2002; 13: 2125-2132.
13. Beddhu S, Samore MH, Roberts MS et al. Impact of timing of initiation of dialysis on mortality. J Am Soc Nephrol 2003; 14: 2305-2312.
14. Kazmi WH, Gilbertson DT, Obrador GT et al. Effect of comorbidity on the increased mortality associated with early initiation of dialysis. Am J of Kidney Dis 2005; 46: 887-896.
15. Rosansky SJ, Eggers P, Jackson K et al. Early start of hemodialysis may be harmful. Arch Intern Med 2011; 171: 396-403.
16. Bao Y, Dalrymple L, Chertow G et al. Frailty, dialysis initiation, and mortality in end-stage renal disease. Arch Intern Med 2012; 172: 1071-1077.
17. Lassalle M, Labeeuw M, Frimat L et al. Age and comorbidity may explain the paradoxical association of an early dialysis start with poor survival. Kidney Int 2010; 77: 700-707.
18. Fang G, Brooks JM, Chrischilles EA. Comparison of instrumental variable analysis using a new instrument with risk adjustment methods to reduce confounding by indication. Am J Epidemiol 2012; 175: 1142-1151.
19. Brunelli SM, Rassen JA. Emerging analytical techniques for comparative effectiveness research. Am J Kidney Dis 2012; 61: 13-17.
20. Brookhart M, Rassen J, Schneeweiss S. Instrumental variable methods in comparative safety and effectiveness research. Pharmacoepidemiol Drug Saf 2010; 19: 537-554.
21. Angrist J, Imbens G, Rubin D. Identification of causal effects using instrumental variables. J Am Stat Assoc 1996; 91: 444-472.
22. van de Luijtgaarden M, Noordzij M, Tomson C et al. Factors influencing the decision to start renal replacement therapy: results of a survey among European nephrologists. Am J Kidney Dis 2012; 60: 940-948.
23. Staiger D, Stock J. Instrumental variables regression with weak instruments. Econometrica 1997; 65: 557-586.
24. Terza JV, Basu A, Rathouz PJ. Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling. J Health Econ 2008; 27: 531-543.
25. Harris A, Cooper BA, Li JJ et al. Cost-effectiveness of initiating dialysis early: a randomized controlled trial. Am J Kidney Dis 2011; 57: 707-715.
26. McKee M, Britton A, Black N et al. Methods in health services research. Interpreting the evidence: choosing between randomised and nonrandomised studies. BMJ 1999; 319: 312-315.
27. Sox HC, Greenfield S. Comparative effectiveness research: a report from the Institute of Medicine. Ann Intern Med 2009; 151: 203-205.
28. Harris KM, Remler DK. Who is the marginal patient? Understanding instrumental variables estimates of treatment effects. Health Serv Res 1998; 33: 1337-1360.
29. Wright S, Klausner D, Baird B et al. Timing of dialysis initiation and survival in ESRD. Clin J Am Soc Nephrol 2010; 5: 1828-1835.
30. Crews D, Scialla J, Liu J et al. Predialysis health, dialysis timing, and outcomes among older United States adults. J Am Soc Nephrol 2014; 25: 370-379.
31. Myers G, Miller W, Coresh J et al. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 2006; 52: 5-18.
32. Brookhart MA, Schneeweiss S. Preference-based instrumental variable methods for the estimation of treatment effects: assessing validity and interpreting results. Int J Biostat 2007; 3: Article 14.
33. Thompson S, Gill J, Wang X et al. Higher mortality among remote compared to rural or urban dwelling hemodialysis patients in the United States. Kidney Int 2012; 82: 352-359.
34. Robinson BM, Joffe MM, Pisoni RL et al. Revisiting survival differences by race and ethnicity among hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study. J Am Soc Nephrol 2006; 17: 2910-2918.
35. Sjolander A, Nyren O, Bellocco R et al. Comparing different strategies for timing of dialysis initiation through inverse probability weighting. Am J Epidemiol 2011; 174: 1204-1210.
36. Levey AS, Coresh J, Greene T et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254.
37. Liu J, Huang Z, Gilbertson DT et al. An improved comorbidity index for outcome analyses among dialysis patients. Kidney Int 2010; 77: 141-151.
38. US Census Bureau. Census 2000 Data for the United States. http:// www.census.gov/census2000/states/us.html, 2000.
39. Rural Health Research Center. Rural-Urban Commuting Area Codes (RUCAs). http://www.depts.washington.edu/uwruca/(Accessed 26 July 2012).
40. American Medical Association. AMA Physician Masterfile. http://www. ama-assn.org/ama/pub/about-ama/physician-data-resources/physicianmasterfile. page? 2013.
41. Baker LC. Measuring competition in health care markets. Health Serv Res 2001; 36: 223-251.
42. Waller L, Carlin B, Xia H et al. Hierarchical spatio-temporal mapping of disease rates. J Am Stat Assoc 1997; 92: 607-617.
43. Liu J, Louis TA, Pan W et al. State-level adjusted ESRD incident rates: use of observed vs. model-predicted category-specific rates. Kidney Int 2006; 69: 1459-1463.